Single Patient, Compassionate Use of MARGETUXIMAB for the Treatment of HER2+ Metastatic Breast Cancer



Status:Available
Conditions:Breast Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:4/29/2017
Contact:Sutton Edlich
Email:edlichs@macrogenics.com
Phone:(240) 552-8082

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The purpose of this study is to determine whether patients treated with margetuximab plus
chemotherapy have longer progression free survival and overall survival than patients
treated with trastuzumab plus chemotherapy.


Inclusion Criteria:

Exclusion Criteria:
We found this trial at
2
sites
Kaiser Foundation Research Institute
1800 Harrison Street
Oakland, California 94612
?
mi
from
Oakland, CA
Click here to add this to my saved trials
Arlington Cancer Center/Texas Health Physicians Group
906 West Randol Mill Road
Arlington, Texas 76012
?
mi
from
Arlington, TX
Click here to add this to my saved trials